Sanofi-Aventis (France) to Invest $90 Million in Lantus in China
Reuters - Sanofi-Aventis (SASY.PA), the world's fourth-biggest drug maker, will invest $90 million to boost output of the insulin Lantus in China, the company said in a statement on Tuesday.